Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
Kathrin Dvir, MD, MSc, discusses how biomarker-driven care, targeted therapies, and evolving sequencing are shaping modern breast cancer treatment. Although many patients across the breast cancer ...
Some six years after the FDA approved Eli Lilly’s Retevmo to treat lung and thyroid cancers that have a mutation or fusion to the RET gene, the Indianapolis drugmaker is laying groundwork to move the ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for ...
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...
SAN FRANCISCO , CA, UNITED STATES, January 14, 2026 /EINPresswire.com/ — Ainnocence today announced a major milestone in artificial-intelligence driven drug ...
A first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people’s lung cells has been fast-tracked towards potential approval after promising clinical trial results. “Very ...
Hosted on MSN
Triad doctor speaks on non-invasive heart treatments
GREENSBORO, N.C. (WGHP) — February is American Heart Month. Dr. Franck Azobou Tonleu with Cone Health talks about non-invasive treatments in cardiology. Copyright ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results